We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$101B
AUM Growth
+$1.35B
Cap. Flow
-$4.96B
Cap. Flow %
-4.94%
Top 10 Hldgs %
23.35%
Holding
4,580
New
415
Increased
1,757
Reduced
1,748
Closed
392

Sector Composition

Rank Sector Weight
1 Technology 8.49%
2 Financials 8.1%
3 Healthcare 6.8%
4 Energy 6.64%
5 Industrials 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LHCG
3076
DELISTED
LHC Group LLC
LHCG
$749K ﹤0.01%
31,915
+1,586
+5% +$36.3K
SINA
3077
DELISTED
Sina Corp
SINA
$749K ﹤0.01%
9,227
-18,306
-66% -$1.34M
WSBC icon
3078
WesBanco
WSBC
$3.97B
$748K ﹤0.01%
25,153
+12,455
+98% +$364K
BEBE
3079
DELISTED
Bebe Stores Inc
BEBE
$746K ﹤0.01%
12,254
+209
+2% +$12.2K
SUB icon
3080
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$743K ﹤0.01%
7,001
-1,085
-13% -$115K
GFF icon
3081
Griffon
GFF
$3.95B
$742K ﹤0.01%
59,196
+5,435
+10% +$64.5K
NGS icon
3082
Natural Gas Services Group
NGS
$472M
$742K ﹤0.01%
27,679
+7,953
+40% +$208K
PZA icon
3083
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.22B
$742K ﹤0.01%
32,152
-8,728
-21% -$201K
LXRX icon
3084
Lexicon Pharmaceuticals
LXRX
$1.03B
$741K ﹤0.01%
44,488
+6,644
+18% +$111K
RVT icon
3085
Royce Value Trust
RVT
$2.21B
$741K ﹤0.01%
49,860
+1,286
+3% +$18.7K
CTIC
3086
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$740K ﹤0.01%
45,667
+32,328
+242% +$375K
FCF icon
3087
First Commonwealth Financial
FCF
$2.18B
$739K ﹤0.01%
97,389
+33,283
+52% +$253K
MVC
3088
DELISTED
MVC Capital, Inc.
MVC
$739K ﹤0.01%
56,535
+21,687
+62% +$276K
SCLN
3089
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$737K ﹤0.01%
145,287
+92,415
+175% +$515K
UBNK
3090
DELISTED
UNITIED FINANCIAL BANCORP INC
UBNK
$736K ﹤0.01%
45,543
+4,963
+12% +$79.6K
CVBF icon
3091
CVB Financial
CVBF
$3.94B
$735K ﹤0.01%
54,305
+5,275
+11% +$69.1K
AGQ icon
3092
ProShares Ultra Silver
AGQ
$1.15B
$734K ﹤0.01%
+9,154
New +$736K
AMT icon
3093
CALL
American Tower
AMT
$80.8B
$734K ﹤0.01%
+9,900
New +$715K
BCOV
3094
DELISTED
Brightcove, Inc.
BCOV
$734K ﹤0.01%
65,208
+18,494
+40% +$186K
PRIM icon
3095
Primoris Services
PRIM
$4.58B
$733K ﹤0.01%
28,787
-56,602
-66% -$1.28M
THFF icon
3096
First Financial Corp
THFF
$958M
$732K ﹤0.01%
23,185
+6,702
+41% +$215K
ZINC
3097
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
$732K ﹤0.01%
58,820
+17,860
+44% +$223K
VV icon
3098
Vanguard Morningstar Large-Cap ETF
VV
$52.4B
$731K ﹤0.01%
9,447
-127,263
-93% -$9.79M
HMIN
3099
DELISTED
HOMEINNS HOTEL GROUP SPONSORED ADR
HMIN
$731K ﹤0.01%
22,027
+9,166
+71% +$282K
CLMS
3100
DELISTED
Calamos Asset Management, Inc.
CLMS
$730K ﹤0.01%
73,021
+18,895
+35% +$197K

Similar funds

Credit Suisse's Q3 2013 Portfolio in Review

As of Q3 2013, Credit Suisse held 4,580 positions worth $101B, up 1.4% from $99.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Credit Suisse withdrew a net $4.96B in Q3 2013, closing 392 positions and reducing 1,748 holdings. Its most notable exit was SPRINT CORP FON COM, an estimated $61.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 8.5% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Credit Suisse opened a new position in Oracle worth $377M.

  • Credit Suisse's largest Q3 2013 buy was Oracle: 11,353,599 shares worth $377M.
  • Credit Suisse added most to iShares US Real Estate ETF in Q3 2013, an estimated $470M increase.
  • Credit Suisse's biggest Q3 2013 reduction was Pfizer, cutting an estimated $800M.
  • Credit Suisse fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $61.3M.
  • Credit Suisse's ten largest holdings make up 23% of its $101B portfolio in Q3 2013.
  • Credit Suisse opened 415 new positions and closed 392 in Q3 2013.
  • Credit Suisse's portfolio value rose 1.4% quarter-over-quarter to $101B.

Based on Credit Suisse's 13F filing for Q3 2013, filed 13 Nov 2013.